Zacks Research Issues Negative Outlook for Chemours Earnings

The Chemours Company (NYSE:CC) – Research analysts at Zacks Research lowered their Q1 2025 earnings estimates for shares of Chemours in a report released on Monday, March 3rd. Zacks Research analyst R. Department now anticipates that the specialty chemicals company will post earnings per share of $0.18 for the quarter, down from their previous forecast of $0.51. The consensus estimate for Chemours’ current full-year earnings is $2.03 per share. Zacks Research also issued estimates for Chemours’ Q4 2025 earnings at $0.31 EPS, FY2025 earnings at $1.61 EPS, Q1 2026 earnings at $0.45 EPS, Q3 2026 earnings at $0.78 EPS and Q4 2026 earnings at $0.47 EPS.

Chemours (NYSE:CC) last posted its quarterly earnings results on Tuesday, February 18th. The specialty chemicals company reported $0.11 earnings per share for the quarter, beating analysts’ consensus estimates of $0.10 by $0.01. Chemours had a net margin of 1.51% and a return on equity of 26.54%. The company had revenue of $1.36 billion for the quarter, compared to the consensus estimate of $1.37 billion.

CC has been the topic of several other reports. BMO Capital Markets cut their target price on shares of Chemours from $34.00 to $27.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 19th. Truist Financial started coverage on shares of Chemours in a research note on Tuesday, January 28th. They issued a “buy” rating and a $27.00 price objective for the company. Morgan Stanley lowered their price objective on shares of Chemours from $25.00 to $22.00 and set an “equal weight” rating for the company in a research note on Monday, January 13th. The Goldman Sachs Group lowered their price objective on shares of Chemours from $24.00 to $21.00 and set a “neutral” rating for the company in a research note on Tuesday, January 7th. Finally, Barclays decreased their price target on shares of Chemours from $23.00 to $19.00 and set an “equal weight” rating for the company in a research note on Monday, February 24th. Five investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $23.11.

Chemours Trading Up 5.3 %

CC opened at $14.12 on Thursday. The company’s 50 day moving average is $17.70 and its 200-day moving average is $18.76. Chemours has a 1-year low of $13.31 and a 1-year high of $29.21. The company has a current ratio of 1.68, a quick ratio of 0.92 and a debt-to-equity ratio of 6.70. The company has a market cap of $2.11 billion, a P/E ratio of 24.76 and a beta of 1.81.

Hedge Funds Weigh In On Chemours

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Strategic Financial Concepts LLC purchased a new position in shares of Chemours in the 4th quarter worth about $357,000. Vision One Management Partners LP purchased a new stake in Chemours during the third quarter valued at about $28,252,000. Two Sigma Advisers LP lifted its holdings in Chemours by 9.4% during the third quarter. Two Sigma Advisers LP now owns 503,100 shares of the specialty chemicals company’s stock valued at $10,223,000 after purchasing an additional 43,200 shares during the last quarter. Entropy Technologies LP purchased a new stake in Chemours during the fourth quarter valued at about $266,000. Finally, Twelve Points Wealth Management LLC lifted its holdings in Chemours by 42.8% during the fourth quarter. Twelve Points Wealth Management LLC now owns 78,325 shares of the specialty chemicals company’s stock valued at $1,324,000 after purchasing an additional 23,490 shares during the last quarter. 76.26% of the stock is owned by hedge funds and other institutional investors.

Chemours Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 14th. Shareholders of record on Friday, February 28th will be issued a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 7.08%. The ex-dividend date of this dividend is Friday, February 28th. Chemours’s dividend payout ratio is 175.44%.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.